Current Challenges and Future Developments in Metabonomics Technology

Metabonomics in Toxicity Assessment

Volumn , Issue , 2005, Pages 499-516

  Robertson, Donald G ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950370333     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14117-15     Document Type: Chapter

References (32)

1. Calabrese EJ, Baldwin LA. Chemical hormesis: its historical foundations as a biological hypothesis. Toxicol Pathol 1999; 27: 195-216.
2. Robertson DG, Breider MA, Milad MA. Preclinical safety evaluation of avasimibe in beagle dogs: an ACAT inhibitor with minimal adrenal effects. Toxicol Sci 2001; 59: 324-334.
3. Castle AL, Carver MP, Mendrick DL. Toxicogenomics: a new revolution in drug safety. Drug Discov Today 2002; 7: 728-736.
4. Nicholson JK, Wilson ID. Understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2003; 2: 668-676.
5. Fiehn O. Combining genomics, metabolome analysis, and biochemical modeling to understand metabolic networks. Comp Funct Genom 2001; 2: 155-168.
6. Aardema MJ, MacGregor JT. Toxicology and genetic toxicology in the new era of '‘toxicogenomics’': Impact of ''-omics’' technologies. Mut Res 2002; 499: 13-25.
7. Reo NV. NMR-based metabolomics. Drug Chem Toxicol 2002; 4: 375-382.
8. Robertson DG, Reily MD, Sigler RE, Wells DF, Paterson DA, Braden TK. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol Sci 2000; 57: 326-337.
9. Lewis LL. Key challenges for toxicologists in the 21st century. Trends Pharmacol Sci 2001; 22: 281-285.
10. Gygi SO, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999; 19: 1720-1730.
11. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002; 1: 153-162.
12. Nicholson JK, Higham D, Timbrall JA, Sadler PJ. Quantitative 1H NMR urinalysis studies on the biochemical effects of acute cadmium exposure in the rat. Mol Pharmacol 1989; 36: 398-404.
13. Gartland KP, Anthony ML, Beddell CR, Lindon JC, Nicholson JK. Proton NMR studies on the effects of uranyl nitrate on the biochemical composition of rat urine and plasma. J Pharm Biomed Anal 1990; 8(8-12): 951-954.
14. Nicholson JK, Lindon JC, Holmes E. '‘Metabonomics’': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181-1189.
15. Lindon JC, Nicholson JK, Holmes E, Antii H, Bollard ME, Keun H, Beckonert O, Ebbels TM, Reily MD, Robertson DG, Stevens GJ, Luke P, Breau AP, Cantor GH, Bible RH, Niederhauser U, Senn H, Schlotterbeck G, Sidelmann UG, Laursen SM, Tymiak A, Car BD, Lehman-McKeeman L, Colet J, Loukaci A, Thomas C. Contemporary Issues in Toxicology: the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol Appl Pharmacol 2003; 187: 137-146.
16. Plumb RS, Stumpf CL, Gorenstein MV, Castro-Perez JM, Dear GJ, Anthony M, Sweatman BC, Connor SC, Haselden JN. Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. Rapid Comm Mass Spectrom 2002; 16: 1991-1996.
17. Pham-Tuan H, Kaskavelis L, Daykin CA, Janssen HG. Method development in high-performance liquid chromatography for high-throughput profiling and metabonomic studies of biofluid samples. J Chromatogr 2003; 789: 283-301.
18. Nicholls AW, Nicholson JK, Haselden JN, Waterfield CJ. A metabonomic approach to the investigation of drug-induced phospholipidosis: an NMR spectroscopy and pattern recognition study. Biomarkers 2000; 5: 410-423.
19. Espina JR, Shockcor JP, Herron WJ, Car BD, Contel NR, Ciaccio PJ, Lindon JC, Holmes E, Nicholson JK. Detection of in vivo biomarkers of phospholipidosis using NMR-based metabonomics approaches. Magn Reson Chem 2001; 39: 559-565.
20. Beckwith-Hall BM, Nicholson JK, Nicholls AW, Foxall PJD, Lindon JC, Connor SC, Abdi M, Connelly J, Holmes E. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem Res Toxicol 1998; 11: 260-272.
21. Waters NJ, Holmes E, Williams A, Waterfield CJ, Farrant RD, Nicholson JK. NMR and pattern recognition studies on the time-related metabolic effects of a-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach. Chem Res Toxicol 2001; 14: 1401-1412.
22. Slim RM, Robertson DG, Albassam M, Reily MD, Robosky L, Dethloff LA. Effect of dexamethasone on the metabonomics profile associated with phosphodiesterase inhibitor-induced mesenteric vascular lesions in rats. Toxicol Appl Pharmacol 2002; 183: 108-116.
23. Mortishire-Smith RJ, Skiles GL, Lawrence JW, Spence S, Nicholls AW, Johynson BA, Nicholson JK. Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. Chem Res Toxicol 2004; 17: 165-173.
24. Coen M, Lenz EM, Nicholson JK, Wilson ID, Pognan F, Lindon JC. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem Res Toxicol 2003; 16: 295-303.
25. Lu B, Lawton MP. Data integration in the new era of toxicogenomics. Toxicol Sci 2003; 72(S1): 98.
26. Ruepp SU, Tonge RP, Shaw J, Wallis N, Pognan F. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol Sci 2002; 65: 135-150.
27. Heijne WHM, Stierum RH, Slijper M, van Bladeren PJ, van Ommen B. Toxicogenomics of bromobenzene hepatotoxicity: a combined transcriptomics and proteomics approach. Biochem, Pharmacol 2003; 65: 857-875.
28. MacGregor JT. The future of regulatory toxicology: impact of the biotechnology revolution. Toxicol Sci 2003; 75: 236-248.
29. Bundy JG, Spugeon DJ, Svendsen C, Hankard PK, Osborn D, Lindon JC, Nicholson JK. Earthworm species of the genus Eisenia can be phenotypically differentiated by metabolic profiling. FEBS Lett 2002; 521: 115-120.
30. Brindle JT, Antti H, Homes E, Tranter G, Nicholson JK, Bethell HW, Clarke S, Schofield PM, McKilligin E, Mosedale DE, Grainger DJ. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMRbased metabonomics. Nat Med 2002; 8: 1439-1444.
31. Brindle JT, Nicholson JK, Schofield PM, Grainger DJ, Holmes E. Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst 2003; 18: 32-36.
32. Moolenaar SH, Engelke UFH, Wevers RA. Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann Clin Biochem 2003; 49: 16-24.